LEADER 02179nam1 22003733i 450 
001 VAN0243955
005 20230712094853.637
100   $a20220328d2021       |0itac50      ba
101   $aeng
102   $aCH
105   $a||||    |||||
200 1 $aProbiotic Research in Therapeutics$feditors Indu Pal Kaur (Editor-in-Chief), Parneet Kaur Deol
210   $aCham$cSpringer
215   $avolumi$cill.$d24 cm
463  1$1001VAN0243959$12001 $aˆ1: ‰Applications in Cancers and Immunological Diseases$feditors Indu Pal Kaur (Editor-in-Chief), Parneet Kaur Deol$1210  $aCham$cSpringer$d2021$1215  $aXIV, 367 p.$cill.$d24 cm$v1
463  1$1001VAN0244512$12001 $aˆ2: ‰Modulation of Gut Flora: Management of Inflammation and Infection Related Gut Etiology$feditors Indu Pal Kaur (Editor-in-Chief), Parneet Kaur Deol$1210  $aCham$cSpringer$d2021$1215  $aXVI, 362 p.$cill.$d24 cm$v2
463  1$1001VAN0260851$12001 $aˆ3: ‰Probiotics and Gut Skin Axis?Inside Out and Outside In$feditors Indu Pal Kaur (Editor-in-Chief), Parneet Kaur Deol$1210  $aCham$cSpringer$d2021$1215  $aXIV, 293 p.$cill.$d24 cm$v3
463  1$1001VAN0261226$12001 $aˆ4: ‰Probiotics in Neurodegenerative Disorders$feditors Indu Pal Kaur (Editor-in-Chief) ... [et al.]$1210  $aSingapore$cSpringer$d2022$1215  $aXII, 254 p.$cill.$d24 cm$v4
463  1$1001VAN0260873$12001 $aˆ5: ‰Metabolic Diseases and Gut Bacteria$feditors Indu Pal Kaur ... [et al.]$1210  $aSingapore$cSpringer$d2022$1215  $aXIV, 275 p.$cill.$d24 cm$v5
620   $aCH$dCham$3VANL001889
702  1$aDeol$bParneet K.$3VANV199197
702  1$aKaur$bIndu P.$3VANV199195
712   $aSpringer <editore>$3VANV108073$4650
790  1$aDeol, Parneet Kaur$zDeol, Parneet K.$3VANV202092
790  1$aDeol, P. K.$zDeol, Parneet K.$3VANV202093
790  1$aDeol, P.K.$zDeol, Parneet K.$3VANV202094
790  1$aKaur, Indu Pal$zKaur, Indu P.$3VANV199196
790  1$aKaur, I.P.$zKaur, Indu P.$3VANV202090
790  1$aKaur, I. P.$zKaur, Indu P.$3VANV202091
801   $aIT$bSOL$c20240614$gRICA
912   $fN
912   $aVAN0243955
996   $aProbiotic research in therapeutics$92596964
997   $aUNICAMPANIA